Juno Therapeutics cancer therapy startup raises $120M

Juno Therapeutics cancer therapy startup raises $120M

Source: Puget Sound Business Journal

Scientists from Seattle Children’s Research Institute, Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering Cancer Center have joined together to help launch Juno, a Seattle-based biotechnology company that will bring forward immunotherapies to fight cancer.

Seattle Children’s provides healthcare without regard to race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry) or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.